X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (32) 32
index medicus (27) 27
atherosclerosis (26) 26
animals (23) 23
mice (23) 23
male (17) 17
female (16) 16
peripheral vascular disease (16) 16
cholesterol (15) 15
hematology (13) 13
cardiac & cardiovascular systems (11) 11
lipids (10) 10
mice, inbred c57bl (10) 10
middle aged (10) 10
expression (9) 9
macrophages (9) 9
macrophages - metabolism (9) 9
adult (8) 8
aged (8) 8
mice, transgenic (8) 8
atherogenesis (7) 7
atherosclerosis - etiology (7) 7
cell line (7) 7
cholesterol - blood (7) 7
cholesterol efflux (7) 7
life sciences (7) 7
research (7) 7
risk factors (7) 7
abridged index medicus (6) 6
apoptosis (6) 6
biochemistry & molecular biology (6) 6
cholesterol - metabolism (6) 6
inflammation (6) 6
liver - metabolism (6) 6
low density lipoproteins (6) 6
mice, knockout (6) 6
monocytes (6) 6
analysis (5) 5
atherosclerosis - genetics (5) 5
cells (5) 5
cells, cultured (5) 5
cholesterol, hdl - blood (5) 5
disease (5) 5
high-density-lipoprotein (5) 5
in-vivo (5) 5
lipoproteins - metabolism (5) 5
lipoproteins, ldl - pharmacology (5) 5
macrophages - drug effects (5) 5
metabolism (5) 5
oxidation-reduction (5) 5
time factors (5) 5
transgenic mice (5) 5
abc transporter (4) 4
apolipoproteins e - genetics (4) 4
atherosclerosis - blood (4) 4
atherosclerosis - metabolism (4) 4
biological transport (4) 4
cardiovascular disease (4) 4
cardiovascular diseases (4) 4
cardiovascular-disease (4) 4
cholesterol, ldl - blood (4) 4
decreased atherosclerosis (4) 4
disease models, animal (4) 4
e-deficient mice (4) 4
hdl (4) 4
human health and pathology (4) 4
lipoproteins (4) 4
lipoproteins - genetics (4) 4
macrophage (4) 4
monocytes - metabolism (4) 4
oxidized ldl (4) 4
phagocytosis (4) 4
receptor (4) 4
reverse transcriptase polymerase chain reaction (4) 4
rna, messenger - metabolism (4) 4
triglycerides (4) 4
antioxidative activity (3) 3
aorta - pathology (3) 3
apolipoprotein-a-i (3) 3
apolipoprotein-e (3) 3
apoptosis - immunology (3) 3
artery-disease (3) 3
atherosclerosis - immunology (3) 3
atherosclerosis - pathology (3) 3
atherosclerosis - prevention & control (3) 3
atp binding cassette transporter, sub-family g, member 1 (3) 3
atp-binding cassette transporters - genetics (3) 3
atp-binding cassette transporters - metabolism (3) 3
bone-marrow (3) 3
case-control studies (3) 3
cell movement (3) 3
children (3) 3
colony-stimulating factor (3) 3
cx3c chemokine receptor 1 (3) 3
dendritic cells (3) 3
foam cells - metabolism (3) 3
gene expression (3) 3
gene expression regulation (3) 3
genetic aspects (3) 3
immune system (3) 3
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the American College of Cardiology, ISSN 0735-1097, 12/2018, Volume 72, Issue 25, pp. 3259 - 3269
Serum cholesterol efflux capacity, a biomarker that integrates contributors and modulators of the initial step of the reverse cholesterol transport, has been... 
mortality | CETP | cholesterol efflux | myocardial infarction | HDL cholesterol | SCAVENGER RECEPTOR BI | CARDIAC & CARDIOVASCULAR SYSTEMS | INFUSION | RELEASE | DENSITY-LIPOPROTEIN FUNCTION | ROLES | HIGH-RISK | DISEASE | IMPROVES | Prospective Studies | Follow-Up Studies | Cholesterol - blood | Humans | Middle Aged | Male | Mortality - trends | Biomarkers - blood | ST Elevation Myocardial Infarction - diagnosis | ST Elevation Myocardial Infarction - blood | Cholesterol Ester Transfer Proteins - blood | ST Elevation Myocardial Infarction - mortality | Triglycerides - blood | Aged, 80 and over | Cholesterol, HDL - blood | Cholesterol, LDL - blood | Female | Aged | Cohort Studies | Blood cholesterol | Cardiac patients | Patient outcomes | Mortality | Low density lipoproteins | Atherosclerosis | Triglycerides | Cardiology | Heart attack | Risk factors | Myocardial infarction | Heart attacks | Laboratories | Lipids | Cardiovascular disease | Density | Modulators | Proteins | Confidence intervals | Bioindicators | Lipoproteins (high density) | Hypertension | Efflux | Health risks | Risk analysis | Patients | Low density lipoprotein | Cholesterol | Cholesteryl ester transfer protein | Arteriosclerosis | Coronary vessels | Biomarkers | Data collection | Infarction | Intubation | Diabetes | Transport | Cardiovascular diseases | Health risk assessment
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 2003, Volume 111, Issue 3, pp. 333 - 340
Journal Article
Arteriosclerosis, Thrombosis, and Vascular Biology, ISSN 1079-5642, 10/2013, Volume 33, Issue 10, pp. 2297 - 2305
OBJECTIVE—Alterations of the chemokine receptor CX3CR1 gene were associated with a reduced risk of myocardial infarction in human and limited atherosclerosis... 
atherosclerosis | CX3CR1 protein, mouse | monocytes | chemokine receptors | migration, cell | receptor antagonist | FRACTALKINE | ATHEROGENESIS | LESION FORMATION | CX3CR1 protein | PLAQUES | cell | CCR2(-/-) MICE | mouse | CXCR1 | AORTIC ROOT | DISEASE | migration | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | DECREASED ATHEROSCLEROSIS | Apolipoproteins E - deficiency | Atherosclerosis - genetics | Humans | Monocytes - immunology | Aorta - metabolism | Aortic Diseases - metabolism | Chemokine CX3CL1 - pharmacology | Time Factors | Receptors, LDL - deficiency | Aortic Diseases - prevention & control | Receptors, Chemokine - antagonists & inhibitors | Macrophages - immunology | Aortic Diseases - pathology | Disease Models, Animal | Receptors, LDL - genetics | Atherosclerosis - pathology | Atherosclerosis - immunology | Anti-Inflammatory Agents - pharmacology | Aortic Diseases - immunology | Aorta - drug effects | Mice, Inbred C57BL | Receptors, Chemokine - metabolism | Cells, Cultured | Aorta - immunology | Hypolipidemic Agents - pharmacology | Atherosclerosis - metabolism | Mice, Knockout | Peptides - pharmacology | Aorta - pathology | Monocytes - drug effects | Aortic Diseases - genetics | Animals | Apolipoproteins E - genetics | Ligands | Macrophages - drug effects | Mice | CX3C Chemokine Receptor 1 | Atherosclerosis - prevention & control
Journal Article
Arteriosclerosis, thrombosis, and vascular biology, ISSN 1079-5642, 08/2018, Volume 38, Issue 8, pp. 1913 - 1925
Objective- Erdheim-Chester disease (ECD) is a rare non-Langerhans cell histiocytosis characterized by the infiltration of multiple tissues with lipid-laden... 
Journal Article
Arteriosclerosis, Thrombosis, and Vascular Biology, ISSN 1079-5642, 08/2018, Volume 38, Issue 8, pp. 1913 - 1925
OBJECTIVE—Erdheim-Chester disease (ECD) is a rare non-Langerhans cell histiocytosis characterized by the infiltration of multiple tissues with lipid-laden... 
Journal Article
Arteriosclerosis, Thrombosis, and Vascular Biology, ISSN 1079-5642, 02/2016, Volume 36, Issue 2, pp. 285 - 294
Journal Article
JOURNAL OF CLINICAL INVESTIGATION, ISSN 0021-9738, 02/2003, Volume 111, Issue 3, pp. 333 - 340
The hallmark of early atherosclerosis is the accumulation of lipid-laden macrophages in the subendothelial space. Circulating monocytes are the precursors of... 
RECEPTOR-DEFICIENT MICE | MEDICINE, RESEARCH & EXPERIMENTAL | REDUCES ATHEROSCLEROSIS | FIRM ADHESION | CELLS | IN-VIVO | MONOCYTE CHEMOATTRACTANT PROTEIN-1 | TARGETED DELETION | EXPRESSION | LESIONS | CHEMOKINE FRACTALKINE
Journal Article
European heart journal, ISSN 0195-668X, 2010, Volume 31, Issue 23, pp. 2844 - 2853
Journal Article
European heart journal, ISSN 0195-668X, 2011, Volume 32, Issue 11, pp. 1345 - 1361
Even at low-density lipoprotein cholesterol (LDL-C) goal, patients with cardiometabolic abnormalities remain at high risk of cardiovascular events. This paper... 
Remnants | Triglyceride-rich lipoproteins | Atherosclerosis | Atherogenic dyslipidaemia | Cardiovascular disease | Triglycerides | High-density lipoprotein cholesterol | Cholesterol | Guidelines | INTIMA-MEDIA THICKNESS | METABOLIC SYNDROME | CARDIAC & CARDIOVASCULAR SYSTEMS | ESTER TRANSFER PROTEIN | HEALED MYOCARDIAL-INFARCTION | HDL-CHOLESTEROL | CORONARY-HEART-DISEASE | TYPE-2 DIABETES-MELLITUS | EXTENDED-RELEASE NIACIN | APOLIPOPROTEIN-A-I | ARTERY-DISEASE | Cardiovascular Diseases - etiology | Fibric Acids - therapeutic use | Life Style | Dyslipidemias - complications | Cholesterol, HDL - metabolism | Cardiovascular Diseases - prevention & control | Humans | Risk Factors | Lipid Metabolism | Clinical Trials as Topic | Forecasting | Triglycerides - metabolism | Dyslipidemias - blood | Niacin - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Lipoproteins - metabolism | Cardiovascular Diseases - blood | Fatty Acids, Omega-3 - therapeutic use | Dyslipidemias - prevention & control | Hypolipidemic Agents - therapeutic use | Current Opinion | Kardiologi | atherosclerosis | cardiovascular disease | Cardiac and Cardiovascular Systems | high-density lipoprotein cholesterol | remnants | cholesterol | guidelines | triglycerides | atherogenic dyslipidaemia | triglyceride-rich lipoproteins
Journal Article
14.